Integrated machine learning, pharmacophore screening, and structure-based computational approaches for the identification of novel JAK3 inhibitors.
AIM Janus kinase 3 (JAK3) is a key therapeutic target in autoimmune and inflammatory diseases. This study aimed to identify novel JAK3 inhibitors using an integrated machine learning and structure-based computational approach. MATERIALS AND METHODS Random Forest Regression model was developed from 4,336 JAK3 inhibito...